Beta-lactamase
Escherichia coli
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 50–311 | Not recorded | Beta-lactamase inhibitory protein × 1 (P35804) | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;298 K;20% w/v PEG3350, 0.2 M NaF, 0.1 M Bis-Tris-propane pH 6.5 | Resolution 1.40 Å R-free 0.166 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 7S5S | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 7U48 Clavulanic acid-CTX-M-15 Deposited 2022-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
21–311(291 aa)
|
Mutation:A25P, Q26L | GOL GLYCEROL × 2 LBX (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.67 Å R-free 0.285 |
| 7U48 Clavulanic acid-CTX-M-15 Deposited 2022-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
21–311(291 aa)
|
Mutation:A25P, Q26L | LBX (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.67 Å R-free 0.285 |
| 7U48 Clavulanic acid-CTX-M-15 Deposited 2022-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
21–311(291 aa)
|
Mutation:A25P, Q26L | LBX (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline × 1 SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.67 Å R-free 0.285 |
| 7U49 DFC-CTX-M-15 Deposited 2022-02-28 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
21–311(291 aa)
|
Not recorded | LD0 (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.72 Å R-free 0.323 |
| 7U49 DFC-CTX-M-15 Deposited 2022-02-28 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
21–311(291 aa)
|
Not recorded | LD0 (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.72 Å R-free 0.323 |
| 7U49 DFC-CTX-M-15 Deposited 2022-02-28 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
21–311(291 aa)
|
Not recorded | LD0 (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.72 Å R-free 0.323 |
| 7U4B Ampicillin-CTX-M-15 Deposited 2022-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
21–310(290 aa)
|
Mutation:A48P, Q49L | NW3 (2S,4S)-2-[(1S)-1-{[(2S)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.92 Å R-free 0.270 |
| 7U4B Ampicillin-CTX-M-15 Deposited 2022-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
21–310(290 aa)
|
Mutation:A48P, Q49L | NW3 (2S,4S)-2-[(1S)-1-{[(2S)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.92 Å R-free 0.270 |
| 7U4B Ampicillin-CTX-M-15 Deposited 2022-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
21–310(290 aa)
|
Mutation:A48P, Q49L | NW3 (2S,4S)-2-[(1S)-1-{[(2S)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 1.92 Å R-free 0.270 |
| 7U57 apo-CTX-M-15 Deposited 2022-03-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
21–311(291 aa)
|
Mutation:A25P, Q26L | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 2.37 Å R-free 0.327 |
| 7U57 apo-CTX-M-15 Deposited 2022-03-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
21–311(291 aa)
|
Mutation:A25P, Q26L | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 2.37 Å R-free 0.327 |
| 7U57 apo-CTX-M-15 Deposited 2022-03-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
21–311(291 aa)
|
Mutation:A25P, Q26L | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;293 K;300 mM Ammonium sulfate, 30% PEG 4000
|
Resolution 2.37 Å R-free 0.327 |
4 other PDB entries and 12 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | C7S9T0_ECOLX |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–262; UniProt 50–311 |